Health informatics

AI in Medical Imaging Market Size to Garner USD 14,271.80 Million by 2032 | Precedence Research

Retrieved on: 
Thursday, November 30, 2023
Cloud, Deep learning, Acquisition, Magnetic resonance imaging, Spanish National Health System, Synthetic media, Surgeon, Informatics, Patient, Strategic planning, Algorithm, Radiology, Diagnosis, Growth, Workload, GE HealthCare, Artificial intelligence, Anatomy, USD, MRI, Health, Physician, Face, X-ray, Medicine, Computer, Feedback, Vuno, NHS, Patent, FDA, Intelligence, Software, Medical imaging, Survival, Google Cloud, Health informatics, Environment, Medical device, Speciality chemicals, Pharmaceutical industry, AI, Biology

The increasing implementation of AI imaging solutions in surgical workflows presents transformative opportunities within the medical imaging market.

Key Points: 
  • The increasing implementation of AI imaging solutions in surgical workflows presents transformative opportunities within the medical imaging market.
  • Medical Imaging Displays Market: The global medical imaging displays market size was valued at USD 5.24 billion in 2022 and it is expected to hit around USD 9.14 billion by 2032, expanding at a CAGR of 5.72% from 2023 to 2032.
  • Medical Imaging Outsourcing Market: The global medical imaging outsourcing market size was valued at USD 8.26 Billion in 2022 and is expected to reach USD 11.92 Billion by 2032, with a compound annual growth rate (CAGR) of 4% during the forecast period 2023 to 2032.
  • Point-of-Care Medical Imaging Market: The global point-of-care medical imaging market size was exhibited at USD 3.72 billion in 2022 and it is expected to hit around USD 5.9 billion by 2032, growing at a CAGR of 4.72% during the forecast period from 2023 to 2032.

AI in Medical Imaging Market Size to Garner USD 14,271.80 Million by 2032| Precedence Research

Retrieved on: 
Thursday, November 30, 2023
Cloud, Deep learning, Acquisition, Magnetic resonance imaging, Spanish National Health System, Synthetic media, Surgeon, Informatics, Patient, Strategic planning, Algorithm, Radiology, Diagnosis, Growth, Workload, GE HealthCare, Artificial intelligence, Anatomy, USD, MRI, Health, Physician, Face, X-ray, Medicine, Computer, Feedback, Vuno, NHS, Patent, FDA, Intelligence, Software, Medical imaging, Survival, Google Cloud, Health informatics, Environment, Medical device, Speciality chemicals, Pharmaceutical industry, AI, Biology

For instance, In the U.S., Medic Vision and Gateway Diagnostic Imaging have completed an innovative research project aimed at improving MRI efficiency using artificial intelligence (AI) in medical imaging.

Key Points: 
  • For instance, In the U.S., Medic Vision and Gateway Diagnostic Imaging have completed an innovative research project aimed at improving MRI efficiency using artificial intelligence (AI) in medical imaging.
  • The increasing implementation of AI imaging solutions in surgical workflows presents transformative opportunities within the medical imaging market.
  • Medical Imaging Displays Market: The global medical imaging displays market size was valued at USD 5.24 billion in 2022 and it is expected to hit around USD 9.14 billion by 2032, expanding at a CAGR of 5.72% from 2023 to 2032.
  • In April 2023, Medical artificial intelligence (AI) solution company Vuno received a US patent for its AI-based medical image analysis technology.

FDB Recognized by AMIA for Decades-Long Partnership & Contributions to Healthcare Informatics

Retrieved on: 
Monday, November 13, 2023
Organization, Human, Associate, Research, First Databank, EHR, Vanderbilt University Medical Center, SAN, Health policy, Intuitive Surgical, Pediatrics, Doctor of Pharmacy, American Medical Informatics Association, Science, FACS, Health, Consumer health informatics, Republican Scientific Medical Library, FDB, Doctor of Philosophy, AMIA, Knowledge, Health informatics, Public, Education, Nursing, Informatics, Surgery, MD

SOUTH SAN FRANCISCO, Nov. 13, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that it has received the Silver Corporate Partner Award presented by the American Medical Informatics Association (AMIA), the leading professional association for informatics professionals in healthcare. AMIA formally recognized FDB for this award for its generous contributions to the association and to the field of informatics at the AMIA 2023 Annual Symposium in New Orleans today.

Key Points: 
  • AMIA formally recognized FDB for this award for its generous contributions to the association and to the field of informatics at the AMIA 2023 Annual Symposium in New Orleans today.
  • As the voice of the nation's top biomedical and health informatics professionals, AMIA and its members play a leading role in assessing the effect of health innovations on health policy and advancing the field of healthcare informatics.
  • AMIA actively supports five domains in healthcare informatics: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.
  • Organizations, such as FDB, that strategically partner with AMIA demonstrate that they are industry leaders with valuable content and expertise to share.

MatrixCare’s Electronic Health Record Platform to Deliver Operational Efficiency and Improved Clinical Outcomes Across 140 Saber Healthcare Group Affiliated Communities

Retrieved on: 
Thursday, November 2, 2023
Community, Quality of life, EHR, Health informatics, Organization, Informatics, Sabre, Senior living, Long-term care, Nursing, Management

BLOOMINGTON, Minn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MatrixCare, a leader in out-of-hospital healthcare technology solutions, is thrilled to announce the expansion of its relationship with Saber Healthcare Group affiliated Communities.

Key Points: 
  • BLOOMINGTON, Minn., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MatrixCare, a leader in out-of-hospital healthcare technology solutions, is thrilled to announce the expansion of its relationship with Saber Healthcare Group affiliated Communities.
  • Saber-affiliated 140 long-term care facilities (“Communities”) will transition to MatrixCare’s Electronic Health Record (EHR) solution, enabling even greater collaboration, integration, and scale efficiencies, ultimately providing a better care delivery experience for all.
  • The decision to expand this collaboration follows realized improvements in the Communities’ operations through the use of MatrixCare’s advanced clinical and compliance tools.
  • “MatrixCare faced the challenge of rapidly proving their capabilities,” said Bill Weisberg, president of Saber Healthcare Group.

Lieutenant General H.R. McMaster Joins Biobot Analytics' Board of Advisors

Retrieved on: 
Wednesday, November 1, 2023
Former, Lieutenant general, Free World, Central Waqf Council, Harvard Medical School, Epidemiology, Joint Chiefs of Staff, Stanford University, Arizona State University, Health, Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, McMaster, United States Department of the Army, Boston Children's Hospital, Doctor of Philosophy, Lieutenant, University of North Carolina at Charlotte, Chapel Hill, Health informatics, Bangladesh Technical Education Board, Postgraduate education, Informatics, Business, Joseph M. Katz Graduate School of Business, University, National Security Affairs Cell, Fellow, Defense, Distinguishing, Hospital, Chief of staff, Hoover Institution, National security advisor, United States biological defense program

CAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, today announced that Lieutenant General H.R. McMaster, Former U.S. National Security Advisor, has joined the company's Board of Advisors. Lt. General H.R. McMaster will help develop and advise Biobot's international expansion as well as the company's new national security business unit.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- Biobot Analytics, a global leader in wastewater epidemiology, today announced that Lieutenant General H.R.
  • McMaster, Former U.S. National Security Advisor, has joined the company's Board of Advisors.
  • McMaster will help develop and advise Biobot's international expansion as well as the company's new national security business unit.
  • McMaster brings a wealth of experience and relationships in the national security space both domestically and abroad to the Biobot team.

Megan Callahan Joins Welsh, Carson, Anderson & Stowe as an HCIT Operating Partner

Retrieved on: 
Wednesday, November 1, 2023
WCAS, MPH, Public health, SVP, General partnership, Kinetik, Welsh, Carson, Anderson & Stowe, Health informatics, Growth, Transport, UCLA, Patient, Management

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Megan Callahan has joined the Firm as an Operating Partner focused on Healthcare Information Technology (HCIT).

Key Points: 
  • NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today that Megan Callahan has joined the Firm as an Operating Partner focused on Healthcare Information Technology (HCIT).
  • Ms. Callahan is an accomplished executive with 25 years of experience leading and growing HCIT companies.
  • Before joining WCAS, Ms. Callahan served as the Chief Operating Officer of Twill, overseeing all commercial, clinical, and people functions.
  • Megan's deep experience and proven leadership building next generation HCIT companies makes her a perfect fit for her role at WCAS."

Barclays appoints Jed Brody as Head of Americas Healthcare Banking

Retrieved on: 
Thursday, October 19, 2023
Banking, Professional Services, Finance, Sale, Health care, Investment banking, Acquisition, ICU, SVB Securities, UnitedHealth Group, Health informatics, SVB, LHC, Advent International, CVS, Lehman Brothers, WellCare, Television, Barclays

Barclays today announces the appointment of Jed Brody as a Managing Director and Head of Americas Healthcare Banking.

Key Points: 
  • Barclays today announces the appointment of Jed Brody as a Managing Director and Head of Americas Healthcare Banking.
  • Mr. Brody will be based in New York, and report to Rick Landgarten, Global Head of Healthcare and Real Estate Investment Banking.
  • Other recent hires and appointments in Barclays’ Healthcare Investment Banking group include Jon Swope being appointed to the Healthcare Information Technology Banking team, and Maneet Singh and Evan Matlin being named Co-Heads of M&A Healthcare in the US.
  • In addition, Jim Birchenough was appointed as Chairman of Global Healthcare Investment Banking and Co-Head of Global Biopharma Investment Banking, Alexis de Rosnay as Co-Head of Global Biopharma Investment Banking and Chairman of Global Healthcare Investment Banking, and Jeff Ammerman as Global Head of Specialty Pharmaceuticals Investment Banking.

CIO Leadership: Leading as the CEO of Technology Will Drive the Discussion at the 2023 Minneapolis CIO Executive Leadership Summit on November 2

Retrieved on: 
Thursday, October 5, 2023
Southwest Value Partners, Division, Darktrace, Hyatt Regency San Francisco, Point Loma Nazarene University, UC San Diego Health, CISO, Wiz, Medtronic, Security, Box, Zoom, Ping Identity, Silicon, Blaj, AI, SAP, Partner, Fellow, Fortinet, Npower, SVP, Pure Storage, Information, Schneider Electric, Berkshire Hathaway, Computer science, Health informatics, Population health, Tata Communications, Product marketing, CIO, RingCentral, BetterCloud, Professor, SentinelOne, Salt Lake City Union Pacific Depot, Gleaning, LastPass, Chief digital officer, HMG, City centre, Retail, Consultant, Management, Drug, Mobile phone, Unisys, Tangoe, Akamai Technologies, Tonkean macaque, Upwork, Tanium, Aventine

Key topics to be explored at the summit will include the role of the CIO as the CEO of Technology to help anticipate what’s next for the business.

Key Points: 
  • Key topics to be explored at the summit will include the role of the CIO as the CEO of Technology to help anticipate what’s next for the business.
  • Looking ahead, HMG Strategy will also be hosting its 2023 Silicon Valley CIO Executive Leadership Summit on October 17 at the Hyatt Regency Santa Clara.
  • Key topics to be explored at the summit include the role of the CIO as the CEO of technology in preparing the organization for what’s coming next.
  • To learn more about the 2023 San Diego Technology Executive Leadership Summit in Partnership with SIM San Diego and to register for the event, click here .

Amylyx Pharmaceuticals Announces Publication of Survival Analysis Comparing CENTAUR to Historical Clinical Trial Control

Retrieved on: 
Tuesday, October 10, 2023
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, ACT, Amylyx Pharmaceuticals, ALS, ALS Association, Doctor of Philosophy, Survival analysis, Death, OLE, American Academy, Pro-Act by VTC, Innovation, Health informatics, Propensity score matching, MD, Risk, NCRI, Mass, Mortality, Massachusetts General Hospital, Survival, Hospital, Disease, Translation, CIB, Principal, AMX0035, Database, ITT, Harvard Medical School, Clinical trial, Medication, Common-pool resource, Pharmaceutical industry

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the publication of a post hoc analysis in the peer-reviewed medical journal, Annals of Clinical and Translational Neurology comparing the long term survival of participants in the CENTAUR study versus a historical clinical trial control group.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the publication of a post hoc analysis in the peer-reviewed medical journal, Annals of Clinical and Translational Neurology comparing the long term survival of participants in the CENTAUR study versus a historical clinical trial control group.
  • The post hoc survival analysis published today compared CENTAUR clinical trial participants who received AMX0035 against a propensity score-matched, AMX0035-naïve external control cohort from the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database.
  • These results using an external control aligned with prior analysis using statistical models adjusting for placebo-to-active crossover in CENTAUR ( RPSFTM ).
  • Amylyx donated data from the CENTAUR clinical trial to the PRO-ACT database.

Somatic Mutations in Single-Cell Sequencing: Separating Signal from Noise, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, October 16, 2023
Health informatics, Somatic mutation, Cell, Algorithm, DNA, Whole genome sequencing, SNV calling from NGS data, Doctor of Philosophy, PTA, DNA repair, Harvard Medical School, Cell division, Postdoctoral researcher, Antibiotics, Vaccine

TORONTO, Oct. 16, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into the development of SCAN2 and how this algorithm enables single-cell sequencing with high accuracy for somatic mutations. Somatic mutations arise due to DNA damage or errors in DNA synthesis and are propagated through cell division. Unlike inherited variants, somatic mutations are shared by only a fraction of the cells in an organism. Numerous algorithms have been developed to identify somatic mutations present in clonal populations in cancer cells. But, for non-cancer cells, the majority of somatic mutations — other than those that arise very early in development — are shared by very few cells or can even be private to a single cell. To identify such mutations, new detection techniques are required.

Key Points: 
  • In this free webinar, delve into the development of SCAN2 and how this algorithm enables single-cell sequencing with high accuracy for somatic mutations.
  • TORONTO, Oct. 16, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into the development of SCAN2 and how this algorithm enables single-cell sequencing with high accuracy for somatic mutations.
  • Somatic mutations arise due to DNA damage or errors in DNA synthesis and are propagated through cell division.
  • Join this webinar to gain insights into the SCAN2 algorithm and how it enables single-cell sequencing with high accuracy for somatic mutations.